stemsavelogo

Select Country

877-783-6728 (877-StemSave)

StemSave Blog

ALS Study Utilizes Stem Cells to Illuminate the Role of Astrocytes in Neurodegenerative Disease.

Posted by pamela@stemsave.com on Apr 18, 2015 11:41:00 AM

Researchers led by Dr. Su-Chun Zhang at the University of Wisconsin-Madison Waisman Center are utilizing stem cells in a pre-clinical trial to determine the role of human astrocytes in neurodegenerative diseases such as ALS, Huntington’s disease, and Rhett Syndrome.  The team found that, upon integration into the central nervous system, stem cell-derived astrocytes from patients with ALS replace the astrocytes of the host while disrupting motor function, as though the host also had ALS.

Read More

Topics: ALS, neural stem cells, autologous dental pulp stem cells, Amyotrophic lateral sclerosis, Neurodegenerative disease, neurological disease,, astrocytes, stemsaveblog

Multiple Sclerosis Treatment Becomes Canada’s First MS Stem Cell Clinical Trial.

Posted by taylor@stemsave.com on Mar 5, 2015 8:37:17 AM

The University of Ottawa trial infuses MSCs to reduce inflammation in the central nervous systems of MS patients.

The Multiple Sclerosis Society of Canada has funded Canada’s first stem cell clinical trial to treat multiple sclerosis, conducted by researchers at the University of Ottawa. The trial, called MESCAMS [Mesenchymal Stem Cell Therapy for Canadian MS patients], will comprise MSC infusions to the central nervous system to utilize their ability to regulate autoimmune attacks and reduce inflammation in 40 MS patients.

Read More

Topics: ALS, Phase III, neural stem cells, multiple sclerosis, Brain, clinical trials, Debilitating Diseases, Stemcells, autologousstemcells, Amyotrophic lateral sclerosis, Neurodegenerative disease, stemsaveblog

New York Times: The Eruption of Stem Cell Therapies.

Posted by taylor@stemsave.com on Sep 16, 2014 11:04:35 AM

Mr. Edgar Irastorza is one of thousands of people already benefiting from the progression of stem cell based therapies.

As reported on the front page of the New York Times Science section, clinical applications of stem cell based therapies are accelerating at a rate that will revolutionize the medical field in a matter of years. In the United States alone, there are currently over 4000 therapies in clinical trials for the treatment of heart disease, blindness, spinal cord injuries, diabetes, H.I.V., and other diseases, injuries, and traumas.

Read More

Topics: Muscular Dystrophy, ALS, Parkinson's, Phase III, multiple sclerosis, Heart, Joints, Alzheimer's, burn injuries, Diabetes, Acute Myocardial Infarction, Brain, Heart Failure, clinical trials, Bone, Debilitating Diseases, Phase II, Arthritis, Stemcells, Teeth, autologousstemcells, cartilage, Amyotrophic lateral sclerosis, Brain Tumors, Blindness, stemsaveblog

Motor Neuron Development Accelerated by New Stem Cell Technique

Posted by Kelsey StemSave on Apr 18, 2014 11:01:17 AM

A new procedure in differentiating stem cells will accelerate advances in treating neurological diseases.

A team of researchers at the University of Illinois led by doctors Fei Wang, Qiuhao Qu, and JianJun Cheng, have developed a fast and efficient technique for differentiating stem cells into motor neurons. The researchers added critical signaling molecules and growth factors to the cells much earlier than previous methods, resulting in twice the amount of neurons derived from the cells in half the time.

Read More

Topics: ALS, multiple sclerosis, Debilitating Diseases, Stemcells, autologousstemcells, spinal cord injuries, Amyotrophic lateral sclerosis, Neurodegenerative disease, stemsaveblog

Lou Gehrig’s Disease Treatment Utilizing Stem Cells Advances

Posted by devin@stemsave.com on Mar 25, 2014 11:43:03 AM

The clinical trial utilizing stem cells can lead to advances in both treating and preventing Lou Gehrig's disease.

A team of researchers from the University of Michigan and the University of Emory reported positive results from a phase 1 clinical study utilizing stem cells to treat amyotrophic lateral sclerosis [ALS], Lou Gehrig’s disease. In addition to verifying the safety of the new procedure, the trial revealed some progress in preventing further disease damage to the motor nerves by improving their cellular environment.

Read More

Topics: clinical trials, Debilitating Diseases, Phase II, Stemcells, autologousstemcells, Amyotrophic lateral sclerosis, stemsaveblog

Stem Cell Advance Gives Hope for Neurodegenerative Treatment

Posted by pamela@stemsave.com on Mar 13, 2013 11:18:52 AM

Scientists in the US (UC, UCSD) and China (Wuhan) have found a way to convert stem cells into functional neurons. The researchers were able to suppress an RNA-binding protein, inducing the stem cells to become neurons. This gives hope for a treatment for neurodegenerative diseases such as Huntington’s, Parkinson’s, Alzheimer’s, Multiple Sclerosis, and Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease), which will afflict one in four Americans over their lifetime.

Read More

Topics: Parkinson's, multiple sclerosis, Alzheimer's, Brain, Stemcells, Huntington's, Amyotrophic lateral sclerosis, Neurodegenerative disease, stemsaveblog

AAOMS

AAOMS - American Association of Oral and Maxillofacial Surgeons

 

As the industry leader, StemSave is the only stem cell banking service to be designated as an ASI approved program.

    Recent Posts

    Posts by Topic

    see all